Nkarta
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nkarta and other ETFs, options, and stocks.About NKTX
Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells.
NKTX Key Statistics
Stock Snapshot
The current Nkarta(NKTX) stock price is $2.49, with a market capitalization of 176.51M. The stock trades at a price-to-earnings (P/E) ratio of -1.79.
On 2026-01-24, Nkarta(NKTX) stock traded between a low of $2.39 and a high of $2.60. Shares are currently priced at $2.49, which is +4.2% above the low and -4.2% below the high.
Nkarta(NKTX) shares are trading with a volume of 1.79M, against a daily average of 963.44K.
During the past year, Nkarta(NKTX) stock moved between $1.31 at its lowest and $2.74 at its peak.
During the past year, Nkarta(NKTX) stock moved between $1.31 at its lowest and $2.74 at its peak.
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.